Jiangsu Jumpcan Pharmaceutical Group

Jiangsu Jumpcan Pharmaceutical Group is a prominent Chinese pharmaceutical enterprise focused on the development, manufacturing, and commercialization of patent Chinese medicines and chemical drugs. The company holds a leading position in the pediatric, digestive, and respiratory therapeutic areas, driven by its flagship product, Pudilan Xiaoyan Oral Liquid. Jumpcan operates extensive GMP-certified manufacturing facilities and maintains a robust nationwide sales network in China. Publicly listed on the Shanghai Stock Exchange, the company is increasingly diversifying its portfolio through strategic in-licensing agreements and investment in innovative biologics and small molecules.